Company news
Pharmanutra S.p.a. (MIL:PHN) news
Pharmanutra S.p.a. news releases on 6ix. Latest, Sep 23, 2026: 23/09/2026 - FOUR NEW SUCROSOMIAL® PRODUCTS FOR THE ITALIAN MARKET: PHARMANUTRA ACCELERATES…
Press releases & updates
23/09/2026 - FOUR NEW SUCROSOMIAL® PRODUCTS FOR THE ITALIAN MARKET: PHARMANUTRA ACCELERATES INNOVATION
September 23, 2026
Pharmanutra S p A : 04/06/2026 - PHARMANUTRA JOINS THE EURONEXT TECH LEADERS SEGMENT
June 4, 2026
Pharmanutra S p A : INTERIM MANAGEMENT REPORT AS AT MARCH 31 2026
May 13, 2026
Pharmanutra S p A : Q1 2026 FINANCIAL RESULTS PRESENTATION
May 11, 2026
Pharmanutra S p A : 09/04/2026 - PHARMANUTRA S.P.A. ALONGSIDE “AF CORSE,” FERRARI HYPERCAR’S RACING PARTNER
April 9, 2026
Pharmanutra S p A : ANNUAL FINANCIAL REPORT 31/12/2025
March 27, 2026
Pharmanutra S p A : 2025 FY FINANCIAL RESULTS
March 17, 2026
Pharmanutra S p A : 17/03/2026 - BOD APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31.12.2025
March 17, 2026
Pharmanutra S p A : obtains FDA registration for...
March 12, 2026
Pharmanutra S p A : 23/02/2026 - APPROVAL OF THE BOARD OF DIRECTORS GUIDELINES AND APPOINTMENT OF THE INVESTOR RELATIONS DIRECTOR
February 19, 2026
Pharmanutra S p A : 28/01/2026 - PHARMANUTRA S.P.A. OBTAINS ISO 13485 CERTIFICATION
January 28, 2026
Pharmanutra S p A : 12/01/2026 - SOLID DOUBLE-DIGIT REVENUE GROWTH IN 2025 DRIVEN BY STRONG CONTRIBUTION FROM INTERNATIONAL MARKETS AND NEW BUSINESS UNITS
January 12, 2026
Pharmanutra S p A : INTERIM MANAGEMENT REPORT AS AT 30/09/2025
November 17, 2025
Pharmanutra S p A : 10/11/2025 - BOARD OF DIRECTORS APPROVES THE INTERIM MANANGEMENT REPORT AS OF SEPTEMBER 30, 2025
November 10, 2025
Pharmanutra S p A : 20/10/2025 - SIDERAL® FORTE AWARDED BEST NUTRACEUTICAL PRODUCT AT SPAZIO NUTRIZIONE
October 20, 2025
Pharmanutra S p A : INTERIM MANAGEMENT REPORT 30/06/2025
September 12, 2025
Pharmanutra S p A : H1 2025 FINANCIAL RESULTS
September 8, 2025
Pharmanutra S p A : 08/09/2025 - BOARD OF DIRECTORS APPROVES THE HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2025
September 8, 2025